EVOK
Price
$5.11
Change
-$0.63 (-10.98%)
Updated
Jul 15, 04:59 PM (EDT)
Capitalization
5.17M
SIGA
Price
$6.71
Change
-$0.15 (-2.19%)
Updated
Jul 15, 04:59 PM (EDT)
Capitalization
608.54M
16 days until earnings call
Interact to see
Advertisement

EVOK vs SIGA

Header iconEVOK vs SIGA Comparison
Open Charts EVOK vs SIGABanner chart's image
Evoke Pharma
Price$5.11
Change-$0.63 (-10.98%)
Volume$400
Capitalization5.17M
SIGA Technologies
Price$6.71
Change-$0.15 (-2.19%)
Volume$3.34K
Capitalization608.54M
EVOK vs SIGA Comparison Chart in %
Loading...
EVOK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SIGA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EVOK vs. SIGA commentary
Jul 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EVOK is a StrongBuy and SIGA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 16, 2025
Stock price -- (EVOK: $5.74 vs. SIGA: $6.86)
Brand notoriety: EVOK and SIGA are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: EVOK: 14% vs. SIGA: 89%
Market capitalization -- EVOK: $5.17M vs. SIGA: $608.54M
EVOK [@Pharmaceuticals: Other] is valued at $5.17M. SIGA’s [@Pharmaceuticals: Other] market capitalization is $608.54M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.81B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EVOK’s FA Score shows that 0 FA rating(s) are green whileSIGA’s FA Score has 2 green FA rating(s).

  • EVOK’s FA Score: 0 green, 5 red.
  • SIGA’s FA Score: 2 green, 3 red.
According to our system of comparison, SIGA is a better buy in the long-term than EVOK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EVOK’s TA Score shows that 6 TA indicator(s) are bullish while SIGA’s TA Score has 5 bullish TA indicator(s).

  • EVOK’s TA Score: 6 bullish, 4 bearish.
  • SIGA’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, both EVOK and SIGA are a good buy in the short-term.

Price Growth

EVOK (@Pharmaceuticals: Other) experienced а +116.42% price change this week, while SIGA (@Pharmaceuticals: Other) price change was +1.93% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +63.89%. For the same industry, the average monthly price growth was +5.32%, and the average quarterly price growth was +68.59%.

Reported Earning Dates

EVOK is expected to report earnings on May 13, 2025.

SIGA is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+63.89% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SIGA($609M) has a higher market cap than EVOK($5.17M). EVOK YTD gains are higher at: 29.751 vs. SIGA (26.054). SIGA has higher annual earnings (EBITDA): 84.2M vs. EVOK (-7.29M). SIGA has more cash in the bank: 150M vs. EVOK (4.74M). SIGA has less debt than EVOK: SIGA (564K) vs EVOK (5M). SIGA has higher revenues than EVOK: SIGA (140M) vs EVOK (5.18M).
EVOKSIGAEVOK / SIGA
Capitalization5.17M609M1%
EBITDA-7.29M84.2M-9%
Gain YTD29.75126.054114%
P/E RatioN/A9.24-
Revenue5.18M140M4%
Total Cash4.74M150M3%
Total Debt5M564K887%
FUNDAMENTALS RATINGS
EVOK vs SIGA: Fundamental Ratings
EVOK
SIGA
OUTLOOK RATING
1..100
9523
VALUATION
overvalued / fair valued / undervalued
1..100
43
Fair valued
1
Undervalued
PROFIT vs RISK RATING
1..100
10085
SMR RATING
1..100
9838
PRICE GROWTH RATING
1..100
3547
P/E GROWTH RATING
1..100
7827
SEASONALITY SCORE
1..100
n/a95

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SIGA's Valuation (1) in the Pharmaceuticals Other industry is somewhat better than the same rating for EVOK (43). This means that SIGA’s stock grew somewhat faster than EVOK’s over the last 12 months.

SIGA's Profit vs Risk Rating (85) in the Pharmaceuticals Other industry is in the same range as EVOK (100). This means that SIGA’s stock grew similarly to EVOK’s over the last 12 months.

SIGA's SMR Rating (38) in the Pharmaceuticals Other industry is somewhat better than the same rating for EVOK (98). This means that SIGA’s stock grew somewhat faster than EVOK’s over the last 12 months.

EVOK's Price Growth Rating (35) in the Pharmaceuticals Other industry is in the same range as SIGA (47). This means that EVOK’s stock grew similarly to SIGA’s over the last 12 months.

SIGA's P/E Growth Rating (27) in the Pharmaceuticals Other industry is somewhat better than the same rating for EVOK (78). This means that SIGA’s stock grew somewhat faster than EVOK’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
EVOKSIGA
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
82%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
82%
Momentum
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
74%
MACD
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 7 days ago
79%
Bullish Trend 7 days ago
78%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
79%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
72%
View a ticker or compare two or three
Interact to see
Advertisement
EVOK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SIGA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CPAC6.140.21
+3.54%
Cementos Pacasmayo SAA
SBFG19.210.30
+1.59%
SB Financial Group
AGYS114.620.70
+0.61%
Agilysys
BRKR43.21-0.58
-1.32%
Bruker Corp
MTNB1.00-0.03
-2.91%
Matinas Biopharma Holdings Inc

EVOK and

Correlation & Price change

A.I.dvisor indicates that over the last year, EVOK has been loosely correlated with RDHL. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if EVOK jumps, then RDHL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EVOK
1D Price
Change %
EVOK100%
-4.58%
RDHL - EVOK
33%
Loosely correlated
+0.69%
RMTI - EVOK
30%
Poorly correlated
-1.77%
NBIX - EVOK
28%
Poorly correlated
+1.25%
EOLS - EVOK
26%
Poorly correlated
+0.32%
EVO - EVOK
24%
Poorly correlated
+1.23%
More

SIGA and

Correlation & Price change

A.I.dvisor indicates that over the last year, SIGA has been loosely correlated with EBS. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if SIGA jumps, then EBS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SIGA
1D Price
Change %
SIGA100%
+1.33%
EBS - SIGA
35%
Loosely correlated
-0.82%
CRRTF - SIGA
26%
Poorly correlated
N/A
OGI - SIGA
26%
Poorly correlated
+2.07%
AMRX - SIGA
26%
Poorly correlated
+1.08%
EVOK - SIGA
23%
Poorly correlated
-4.58%
More